Centene Company (NYSE:CNC) is one in every of billionaire Cliff Asness’ prime 10 healthcare inventory picks. On June 23, RBC Capital analyst Ben Hendrix initiated protection of Centene Company (NYSE:CNC) with a Sector Carry out ranking and a value goal of $70.
Valeri Potapova/Shutterstock.com
Hendrix acknowledged that Centene entered 2026 displaying clear early indicators of a restoration, which is a large distinction to the brutal circumstances that outlined 2025. In 2025, the corporate was confronted with hovering medical prices, coverage uncertainty across the Inexpensive Care Act, or ACA, subsidies, and a troublesome Medicaid surroundings. All these collectively impacted the inventory and despatched it to historic lows, the analyst famous.
Hendrix is for certain that Medicaid is a key pillar of the inventory this time round. He expects margins to maintain bettering as state reimbursement charges step by step meet up with the precise medical prices Centene is incurring, which is a lag that had been one of many predominant revenue drags on the enterprise in prior years. On Centene’s ACA trade enterprise, sometimes called the Well being Insurance coverage Market, the analyst additionally views the margin outlook favorably. He pointed to pricing changes Centene has made throughout its ACA portfolio which can be anticipated to enhance profitability going ahead. That is at the same time as the corporate offers with a higher-cost membership base following the expiry of enhanced premium subsidies.
Hendrix additionally sees potential for Centene’s 2026 earnings per share to come back in above its personal steering if danger adjustment receivables stay steady.
Centene Company (NYSE:CNC) is a managed care firm. It supplies medical health insurance protection and associated providers to people and households by government-sponsored packages, together with Medicaid, Medicare, and the Well being Insurance coverage Market.
Whereas we acknowledge the potential of CNC as an funding, we consider sure AI shares supply higher upside potential and carry much less draw back danger. For those who’re on the lookout for an especially undervalued AI inventory that additionally stands to learn considerably from Trump-era tariffs and the onshoring development, see our free report on the greatest short-term AI inventory.
READ NEXT: 10 Finest Shares to Purchase Now for Good Returns and 10 Finest Development Shares to Purchase Based on Billionaire Dan Loeb.
Disclosure: None. Observe Insider Monkey on Google Information.
